Cian McCarthy, Mb.Bch,Bao
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Infarction | 33 | 2024 | 11690 | 4.380 |
Why?
|
Troponin | 9 | 2023 | 524 | 3.130 |
Why?
|
Troponin I | 7 | 2024 | 619 | 2.390 |
Why?
|
Chest Pain | 7 | 2022 | 1113 | 1.710 |
Why?
|
Morphine | 4 | 2017 | 657 | 1.700 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2023 | 45 | 1.670 |
Why?
|
Acute Coronary Syndrome | 9 | 2024 | 2337 | 1.650 |
Why?
|
Patient Readmission | 10 | 2021 | 3111 | 1.580 |
Why?
|
Coronary Stenosis | 4 | 2023 | 834 | 1.220 |
Why?
|
International Classification of Diseases | 5 | 2021 | 865 | 1.020 |
Why?
|
Coronary Angiography | 10 | 2023 | 4567 | 0.990 |
Why?
|
Coronary Artery Disease | 9 | 2023 | 6454 | 0.920 |
Why?
|
Bullying | 2 | 2016 | 209 | 0.890 |
Why?
|
Cardiovascular Diseases | 17 | 2023 | 15108 | 0.840 |
Why?
|
Thrombosis | 4 | 2022 | 2966 | 0.820 |
Why?
|
Vasodilator Agents | 2 | 2017 | 976 | 0.820 |
Why?
|
Teaching Rounds | 2 | 2016 | 253 | 0.820 |
Why?
|
Anticoagulants | 6 | 2022 | 4595 | 0.810 |
Why?
|
Medical Staff, Hospital | 2 | 2016 | 603 | 0.800 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2022 | 3067 | 0.730 |
Why?
|
Plaque, Atherosclerotic | 2 | 2023 | 1499 | 0.720 |
Why?
|
Economics, Hospital | 2 | 2019 | 213 | 0.710 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2023 | 279 | 0.710 |
Why?
|
Troponin T | 3 | 2023 | 749 | 0.630 |
Why?
|
Fibrinolytic Agents | 2 | 2018 | 2156 | 0.620 |
Why?
|
Proteomics | 3 | 2020 | 3618 | 0.610 |
Why?
|
Heart Injuries | 1 | 2019 | 209 | 0.590 |
Why?
|
Health Services Misuse | 1 | 2019 | 243 | 0.580 |
Why?
|
Medicare | 6 | 2024 | 6532 | 0.580 |
Why?
|
Caricatures as Topic | 1 | 2016 | 1 | 0.570 |
Why?
|
Natriuretic Peptides | 1 | 2017 | 150 | 0.560 |
Why?
|
Physicians | 3 | 2020 | 4554 | 0.560 |
Why?
|
Trimetazidine | 1 | 2015 | 2 | 0.560 |
Why?
|
Conflict of Interest | 2 | 2018 | 542 | 0.560 |
Why?
|
Metaphor | 1 | 2016 | 38 | 0.550 |
Why?
|
Cardiology | 4 | 2022 | 1658 | 0.550 |
Why?
|
Patient Care Management | 1 | 2019 | 306 | 0.540 |
Why?
|
Heart Failure | 7 | 2022 | 10856 | 0.540 |
Why?
|
Nitrates | 1 | 2017 | 265 | 0.530 |
Why?
|
Program Development | 2 | 2018 | 1314 | 0.520 |
Why?
|
Specialization | 1 | 2020 | 777 | 0.510 |
Why?
|
Models, Organizational | 1 | 2018 | 574 | 0.500 |
Why?
|
Humans | 90 | 2024 | 742088 | 0.500 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 344 | 0.500 |
Why?
|
Health Status Indicators | 1 | 2020 | 968 | 0.490 |
Why?
|
Prognosis | 17 | 2024 | 29010 | 0.490 |
Why?
|
Peroxidase | 1 | 2017 | 610 | 0.490 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 363 | 0.480 |
Why?
|
Aortic Valve Stenosis | 2 | 2017 | 1941 | 0.470 |
Why?
|
Education, Medical | 2 | 2016 | 1717 | 0.470 |
Why?
|
Predictive Value of Tests | 10 | 2023 | 15056 | 0.470 |
Why?
|
Reimbursement, Incentive | 1 | 2019 | 540 | 0.460 |
Why?
|
Metabolic Diseases | 1 | 2020 | 657 | 0.450 |
Why?
|
Blood Proteins | 1 | 2018 | 1122 | 0.450 |
Why?
|
Warfarin | 2 | 2022 | 1493 | 0.450 |
Why?
|
Students, Medical | 2 | 2016 | 1858 | 0.440 |
Why?
|
Heparin | 1 | 2020 | 1636 | 0.430 |
Why?
|
Risk Assessment | 12 | 2020 | 23320 | 0.420 |
Why?
|
Coronary Vessel Anomalies | 1 | 2015 | 314 | 0.410 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1255 | 0.410 |
Why?
|
Watchful Waiting | 1 | 2016 | 491 | 0.400 |
Why?
|
Hospitalization | 4 | 2022 | 10232 | 0.400 |
Why?
|
Angina Pectoris | 1 | 2015 | 977 | 0.400 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3766 | 0.400 |
Why?
|
Sex Factors | 6 | 2021 | 10392 | 0.400 |
Why?
|
Heart Diseases | 3 | 2021 | 2789 | 0.390 |
Why?
|
Patient Discharge | 3 | 2020 | 3300 | 0.380 |
Why?
|
Disease Management | 2 | 2018 | 2450 | 0.360 |
Why?
|
Medicaid | 3 | 2019 | 2716 | 0.350 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1171 | 0.350 |
Why?
|
Information Dissemination | 1 | 2018 | 1100 | 0.350 |
Why?
|
Practice Guidelines as Topic | 6 | 2020 | 7276 | 0.340 |
Why?
|
Health Care Reform | 1 | 2018 | 1261 | 0.340 |
Why?
|
Thrombolytic Therapy | 1 | 2018 | 2161 | 0.330 |
Why?
|
Coronary Vessels | 2 | 2021 | 3099 | 0.330 |
Why?
|
Analgesics, Opioid | 4 | 2017 | 3667 | 0.330 |
Why?
|
Salaries and Fringe Benefits | 2 | 2021 | 264 | 0.320 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1486 | 0.320 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1184 | 0.320 |
Why?
|
Arrhythmias, Cardiac | 2 | 2024 | 2267 | 0.320 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2059 | 0.310 |
Why?
|
Faculty, Medical | 1 | 2016 | 1182 | 0.300 |
Why?
|
Mitral Valve Insufficiency | 1 | 2017 | 1415 | 0.290 |
Why?
|
United States | 18 | 2024 | 69693 | 0.280 |
Why?
|
Quality of Health Care | 2 | 2018 | 4369 | 0.280 |
Why?
|
Health Policy | 1 | 2018 | 2657 | 0.270 |
Why?
|
Hypertension | 2 | 2023 | 8455 | 0.270 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2016 | 1527 | 0.260 |
Why?
|
Aged | 20 | 2024 | 162944 | 0.260 |
Why?
|
Dyslipidemias | 2 | 2022 | 848 | 0.240 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3507 | 0.230 |
Why?
|
Patient Selection | 1 | 2016 | 4214 | 0.230 |
Why?
|
Male | 30 | 2024 | 349538 | 0.230 |
Why?
|
Acute Kidney Injury | 3 | 2022 | 1967 | 0.230 |
Why?
|
Middle Aged | 21 | 2023 | 213127 | 0.230 |
Why?
|
Aspirin | 3 | 2020 | 3278 | 0.230 |
Why?
|
Echocardiography | 1 | 2016 | 5097 | 0.230 |
Why?
|
Coronary Disease | 2 | 2017 | 6078 | 0.220 |
Why?
|
Prospective Studies | 10 | 2023 | 53187 | 0.220 |
Why?
|
Risk Factors | 14 | 2023 | 72145 | 0.210 |
Why?
|
Survival Analysis | 4 | 2019 | 10248 | 0.210 |
Why?
|
Hospital Mortality | 4 | 2021 | 5310 | 0.210 |
Why?
|
Female | 29 | 2024 | 379592 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3239 | 0.210 |
Why?
|
Incidence | 6 | 2019 | 20928 | 0.200 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1573 | 0.200 |
Why?
|
Massachusetts | 3 | 2019 | 8662 | 0.200 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1066 | 0.190 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15530 | 0.190 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2024 | 489 | 0.190 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7645 | 0.190 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1095 | 0.180 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.170 |
Why?
|
Cause of Death | 2 | 2020 | 3571 | 0.170 |
Why?
|
Catheter Ablation | 2 | 2024 | 2746 | 0.160 |
Why?
|
Sus scrofa | 1 | 2020 | 437 | 0.160 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2019 | 153 | 0.160 |
Why?
|
Comorbidity | 3 | 2024 | 10372 | 0.150 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 550 | 0.150 |
Why?
|
Length of Stay | 3 | 2021 | 6294 | 0.150 |
Why?
|
Insurance, Health | 2 | 2021 | 2493 | 0.150 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 963 | 0.150 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2019 | 371 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6483 | 0.150 |
Why?
|
Apolipoproteins | 1 | 2019 | 315 | 0.140 |
Why?
|
Endothelin-1 | 1 | 2018 | 313 | 0.140 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 261 | 0.140 |
Why?
|
Prevalence | 5 | 2022 | 15194 | 0.140 |
Why?
|
Angiography | 2 | 2022 | 1636 | 0.140 |
Why?
|
Drug Labeling | 1 | 2018 | 231 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2195 | 0.140 |
Why?
|
Coronary Care Units | 1 | 2018 | 214 | 0.140 |
Why?
|
Ischemic Preconditioning, Myocardial | 1 | 2016 | 67 | 0.140 |
Why?
|
Neprilysin | 1 | 2019 | 439 | 0.140 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1179 | 0.140 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 670 | 0.130 |
Why?
|
Referral and Consultation | 2 | 2019 | 3527 | 0.130 |
Why?
|
Hospitals | 2 | 2020 | 3937 | 0.130 |
Why?
|
Catheters | 1 | 2018 | 422 | 0.130 |
Why?
|
ROC Curve | 2 | 2020 | 3528 | 0.130 |
Why?
|
Boston | 2 | 2019 | 9305 | 0.130 |
Why?
|
Retrospective Studies | 7 | 2021 | 77098 | 0.130 |
Why?
|
Aged, 80 and over | 7 | 2024 | 57683 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 934 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2022 | 827 | 0.130 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7770 | 0.130 |
Why?
|
Primary Prevention | 2 | 2019 | 1166 | 0.120 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.120 |
Why?
|
Hospital Costs | 1 | 2021 | 980 | 0.120 |
Why?
|
Models, Economic | 1 | 2018 | 713 | 0.120 |
Why?
|
Adiponectin | 1 | 2020 | 1099 | 0.120 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 841 | 0.120 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1581 | 0.120 |
Why?
|
China | 1 | 2020 | 2246 | 0.120 |
Why?
|
Drug Industry | 1 | 2020 | 744 | 0.120 |
Why?
|
Electrocardiography | 2 | 2019 | 6440 | 0.110 |
Why?
|
Physicians, Women | 1 | 2019 | 487 | 0.110 |
Why?
|
Tetrazoles | 1 | 2019 | 835 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5724 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 11695 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2016 | 476 | 0.110 |
Why?
|
Time Factors | 3 | 2020 | 40054 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2019 | 964 | 0.110 |
Why?
|
Treatment Outcome | 6 | 2019 | 62966 | 0.100 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12958 | 0.100 |
Why?
|
Telemedicine | 2 | 2019 | 2853 | 0.100 |
Why?
|
Disclosure | 1 | 2018 | 736 | 0.100 |
Why?
|
Coronary Occlusion | 1 | 2015 | 303 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2145 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2281 | 0.100 |
Why?
|
Stroke Volume | 2 | 2021 | 4983 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39004 | 0.100 |
Why?
|
Outpatients | 1 | 2018 | 1483 | 0.100 |
Why?
|
Mortality | 2 | 2019 | 2857 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2017 | 1813 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2485 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1788 | 0.090 |
Why?
|
Thrombectomy | 1 | 2015 | 679 | 0.090 |
Why?
|
Bariatric Surgery | 1 | 2019 | 940 | 0.090 |
Why?
|
Hypoglycemic Agents | 2 | 2019 | 2866 | 0.090 |
Why?
|
Income | 1 | 2018 | 1904 | 0.090 |
Why?
|
Contrast Media | 2 | 2022 | 5295 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2018 | 19862 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2016 | 1178 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1636 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 7716 | 0.080 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2637 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3656 | 0.080 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1204 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1541 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7141 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9846 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.080 |
Why?
|
Cohort Studies | 3 | 2019 | 40450 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2354 | 0.080 |
Why?
|
Blood Pressure | 1 | 2023 | 8541 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 24913 | 0.070 |
Why?
|
Survival Rate | 2 | 2019 | 12773 | 0.070 |
Why?
|
Delirium | 1 | 2018 | 1608 | 0.070 |
Why?
|
Aortic Valve | 1 | 2016 | 1911 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4455 | 0.070 |
Why?
|
Health Expenditures | 1 | 2018 | 2346 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2283 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2187 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14720 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 13256 | 0.060 |
Why?
|
Cardiac Electrophysiology | 1 | 2024 | 48 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 8969 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8077 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10578 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12220 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9581 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20086 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15494 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 149 | 0.050 |
Why?
|
Obesity | 2 | 2022 | 12705 | 0.050 |
Why?
|
Censuses | 1 | 2022 | 200 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 21719 | 0.050 |
Why?
|
Cystatin C | 1 | 2022 | 250 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9941 | 0.050 |
Why?
|
New England | 1 | 2024 | 1021 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5019 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2022 | 248 | 0.050 |
Why?
|
Osteopontin | 1 | 2022 | 296 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2015 | 4229 | 0.050 |
Why?
|
Vitamin K | 1 | 2022 | 294 | 0.050 |
Why?
|
Stroke | 1 | 2022 | 9963 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7901 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1055 | 0.040 |
Why?
|
Animals | 3 | 2020 | 168561 | 0.040 |
Why?
|
Hemorrhage | 2 | 2019 | 3461 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1656 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 637 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 914 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2295 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12344 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1520 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2019 | 820 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 1961 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2935 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2970 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1916 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 923 | 0.030 |
Why?
|
Catheterization | 1 | 2018 | 1468 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2895 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 956 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1181 | 0.030 |
Why?
|
Radiography | 1 | 2024 | 7010 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 848 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3199 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1636 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2203 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2167 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6365 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2022 | 3801 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2021 | 2145 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 1067 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2019 | 1895 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8333 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2194 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9144 | 0.020 |
Why?
|
Algorithms | 1 | 2024 | 13853 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12695 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5304 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35342 | 0.010 |
Why?
|
Adult | 1 | 2019 | 213712 | 0.000 |
Why?
|